Pregnancy Complications Affect Future Heart Health
Medically reviewed by Drugs.com.
By Dennis Thompson HealthDay Reporter
FRIDAY, April 18, 2025 -- Complications during pregnancy can mean a woman’s future heart health is at risk, particularly if she is overweight or obese, a new study says.
Women who are carrying excess weight prior to pregnancy are more likely to develop complications like gestational diabetes and high blood pressure while expecting, researchers said.
These complications act as a natural “stress test” that provides a glimpse into a woman’s future health and risks for chronic illness, researchers said.
The results “suggest that prioritizing weight management among those considering pregnancy may promote both maternal and future cardiovascular health,” lead investigator Jaclyn Borrowman, a postdoctoral research fellow at Northwestern University, said in a news release.
For the study, researchers tracked nearly 4,300 women across nine countries, following them for 10 to 14 years after their pregnancy.
About 67% of the women had a normal body mass index (BMI), 22% were overweight and 11% were obese, researchers said. BMI, which stands for body mass index, is an estimate of body fat based on height and weight.
Results showed that women who developed gestational diabetes were more likely later in life to suffer from higher blood glucose levels and other warning signs of type 2 diabetes.
Likewise, those who developed high blood pressure during pregnancy were more likely to have high blood pressure in later life.
However, Borrowman noted that these pregnancy complications only contributed to women’s future heart risk, and did not fully explain away the risk. Other factors are involved.
“Understanding the connection between adverse pregnancy outcomes and cardiovascular disease is important in the development of effective preventative strategies and determining the best timing for intervention to support long-term heart health,” Borrowman said.
In an accompanying editorial, Dr. Garima Sharma said the study provides “insightful information” that could help doctors track women’s heart risk factors following pregnancy.
“The results of the study underscore the value in addressing excess [fatty tissue] in the pre-pregnancy and postpartum period, particularly as there are options with emerging therapies such new anti-obesity medications,” Sharma, director of cardio-obstetrics at Inova Health System in Virginia, said in a news release,
The new study appears in the journal JACC.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-19 00:00
Read more

- ACC: Semaglutide Beneficial in Patients With T2DM and Peripheral Artery Disease
- Rural-Urban Differences Seen in Cardiometabolic Risk Factors, CVD
- In-Hospital Addiction Consultations Put Opioid Users On Path To Recovery
- Link Between Global β-Amyloid, Tau Deposition Varies by Sex
- Chlamydia Vaccine Candidate Granted Fast Track Designation by the US FDA
- Age-Adjusted Ischemic Stroke Mortality Increased Since 2009
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions